The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors

Launched by ISTANBUL MEDENIYET UNIVERSITY · May 18, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how specific release techniques, aimed at loosening the fascia (a type of connective tissue) around the pectoralis major muscle, can help improve shoulder movement for women who have survived breast cancer. After undergoing breast surgery, many women experience limited shoulder mobility, which can be caused by damage to this tissue. The study aims to see if these techniques can help increase the range of motion in their shoulder joints.

To participate, women aged 30 to 60 who have had breast surgery within the last two years and are experiencing shoulder movement limitations may be eligible. Participants should not have received any shoulder rehabilitation treatment in the last six months. Throughout the trial, participants can expect to receive the myofascial release techniques and be monitored for any improvements in their shoulder mobility. It's important to note that certain health conditions, recent surgeries, or ongoing treatments may disqualify some individuals from taking part in this study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women between the ages of 30-60
• • Having breast surgery within 2 years
• • Not have received conservative treatment for shoulder rehabilitation in the last 6 months
• • Having limitation of movement of the shoulder joint due to breast surgery
• Exclusion Criteria:
• • Not having agreed to participate in the study
• • Having undergone radical mastectomy surgery
• • Having connective tissue disease
• • Presence of brachial plexus paresis/plegia
• • Presence of radiogenic fibrosis
• • Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions
• • Presence of active metastases
• • Having undergone reconstruction surgery
• • Continuation of radiotherapy (must have ended at least 3 months ago) or chemotherapy applications
• • Having had a bilateral mastectomy
• • To develop lymphedema in the arm-trunk
• • Use of muscle relaxants
• • Patients with severe chemotherapy side effects (hyperesthesia, nausea, skin changes, weakness, etc.)